Apr 8, 2016 7:00 am EDT VolitionRx to Present at AACR Annual Meeting and Announce First Results from Prostate Cancer Study
Apr 7, 2016 7:08 am EDT VolitionRx Announces CE Marks for Two NuQ® Blood Assays for Detection of Colorectal Cancer
Mar 23, 2016 11:30 am EDT VolitionRx Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
Mar 9, 2016 8:30 am EST VolitionRx Schedules Full-Year 2015 Earnings Conference Call and Business Update for Friday, March 11, 2016 at 8:30am ET
Mar 9, 2016 7:00 am EST Preliminary Data Demonstrates 86% Accuracy in Detecting Idiopathic Pulmonary Fibrosis, a Fatal Lung Disease
Feb 17, 2016 7:00 am EST VolitionRx Demonstrates 75% Accuracy in Detecting Highest-Risk Pre-Cancerous Colorectal Adenomas with NuQ® Blood Test
